Correlation Between TRACON Pharmaceuticals and Erytech Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TRACON Pharmaceuticals and Erytech Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TRACON Pharmaceuticals and Erytech Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TRACON Pharmaceuticals and Erytech Pharma SA, you can compare the effects of market volatilities on TRACON Pharmaceuticals and Erytech Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TRACON Pharmaceuticals with a short position of Erytech Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of TRACON Pharmaceuticals and Erytech Pharma.

Diversification Opportunities for TRACON Pharmaceuticals and Erytech Pharma

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between TRACON and Erytech is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding TRACON Pharmaceuticals and Erytech Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erytech Pharma SA and TRACON Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TRACON Pharmaceuticals are associated (or correlated) with Erytech Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erytech Pharma SA has no effect on the direction of TRACON Pharmaceuticals i.e., TRACON Pharmaceuticals and Erytech Pharma go up and down completely randomly.

Pair Corralation between TRACON Pharmaceuticals and Erytech Pharma

If you would invest  145.00  in TRACON Pharmaceuticals on September 24, 2024 and sell it today you would earn a total of  15.00  from holding TRACON Pharmaceuticals or generate 10.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy25.0%
ValuesDaily Returns

TRACON Pharmaceuticals  vs.  Erytech Pharma SA

 Performance 
       Timeline  
TRACON Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TRACON Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, TRACON Pharmaceuticals is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Erytech Pharma SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Erytech Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Erytech Pharma is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

TRACON Pharmaceuticals and Erytech Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TRACON Pharmaceuticals and Erytech Pharma

The main advantage of trading using opposite TRACON Pharmaceuticals and Erytech Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TRACON Pharmaceuticals position performs unexpectedly, Erytech Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erytech Pharma will offset losses from the drop in Erytech Pharma's long position.
The idea behind TRACON Pharmaceuticals and Erytech Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.